Rasbach Kyle

Insider CIK 2050086 · LXEO Chief Financial Officer

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
LXEO Lexeo Therapeutics, Inc.	A Award deriv	2025-01-17	2025-01-22	245,250	—	$0	245,250	SEC↗
LXEO Lexeo Therapeutics, Inc.	A Award	2025-01-17	2025-01-22	40,875	—	$0	40,875	SEC↗